HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights

Stock Information for Pieris Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Pieris Pharmaceuticals Inc.

HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
HTG Highlights the Advantages of Its Drug Discovery Engine
HTG Provides Update on Drug Discovery Partnering Initiative
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event
HTG Announces Certain Preliminary 2022 Unaudited Financial Results
HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.